Atara Biotherapeutics ATRA
NASDAQ ATRA
$8.46 -0.04 (-0.47%)
At close: Oct 1, 2026 · 4:00 PM EDT

Atara Biotherapeutics (ATRA) Revenue (2021 - 2026)

Updated

Atara Biotherapeutics' Revenue came in at $630,000 for Q2 2026, down 96.4% from $17.58 million a year earlier but up 22.1% from the prior quarter.

Analysis

Atara Biotherapeutics (ATRA) Revenue (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Atara Biotherapeutics reported Revenue of $6.19 million, down 96.7% year-over-year; for FY2025, it came in at $120.77 million, down 6.3% from FY2024.

  • Revenue carries a four-year compound annual growth rate of 56.1% (FY2021 to FY2025).
  • Going back by year, Revenue was $128.94 million in FY2024, $8.57 million in FY2023 (-86.5%), $63.6 million in FY2022 (+212.7%) and $20.34 million in FY2021.
  • The five-year range for quarterly Revenue is $248,000 (Q4 2022) to $98.15 million (Q1 2025).
  • Year-over-year, Revenue has declined for five consecutive quarters, with growth averaging 72.6% over the last seven quarters.
  • The fastest year-over-year change in Revenue over five years came in Q4 2024 (growth of 670.3%), and the weakest in Q1 2026 (a decline of 99.5%).
  • Business Quant data shows ATRA's Revenue at $516,000 (Q1 2026), $1.6 million (Q4 2025) and $3.45 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.31 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 16.99 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.38 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 7.80 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.33 Bn
10 Atara Biotherapeutics 127.78 Mn 117.88 Mn 439,000.00 630,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 630,000.00
Mar 31, 2026 516,000.00
Dec 31, 2025 1.60 Mn
Sep 30, 2025 3.45 Mn
Jun 30, 2025 17.58 Mn
Mar 31, 2025 98.15 Mn
Dec 31, 2024 32.75 Mn
Sep 30, 2024 40.19 Mn
Jun 30, 2024 28.64 Mn
Mar 31, 2024 27.36 Mn
Dec 31, 2023 4.25 Mn
Sep 30, 2023 2.14 Mn
Jun 30, 2023 957,000.00
Mar 31, 2023 1.23 Mn
Dec 31, 2022 248,000.00
Sep 30, 2022 4.46 Mn
Jun 30, 2022 51.58 Mn
Mar 31, 2022 7.31 Mn
Dec 31, 2021 7.55 Mn
Sep 30, 2021 5.37 Mn
API Access

Atara Biotherapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=ATRA&period=max&api_key=YOUR_API_KEY